Issued Patents 2002
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6498140 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-12-24 |
| 6472411 | Advanced glycation end-product intermediaries and post-amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2002-10-29 |
| 6472400 | Advanced gylcation end-product intermediaries and post-Amadori inhibition | Parvin Todd, Raja Khalifah, Aaron Ashley Booth | 2002-10-29 |
| 6448222 | Use of isolated alpha 2 domain of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-09-10 |
| 6440729 | Treating angiogenesis-mediated diseases with the &agr;2 monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-08-27 |
| 6436969 | Dialysis solutions and methods | Raja Khalifah | 2002-08-20 |
| 6432706 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;6 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-08-13 |
| 6419924 | Antibodies of isolated domains of type IV collagen modify cell interactions | Michael P. Sarras, Jr. | 2002-07-16 |
| 6384012 | Use of isolated domains of type IV collagen to modify cell and tissue interactions | Michael P. Sarras, Jr. | 2002-05-07 |
| 6361994 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;1 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-03-26 |
| 6358735 | Method for inhibiting angiogenesis and tumors with the isolated NC1 &agr;3 chain monomer of type IV collagen | Michael P. Sarras, Jr. | 2002-03-19 |